Published in Clin Exp Immunol on September 01, 1981
Cellular defenses against Toxoplasma gondii in newborns. J Clin Invest (1984) 1.05
Pre-B cell suppression by thymoma patient lymphocytes. Clin Exp Immunol (1982) 0.88
Identification of lymphocyte subsets in the newborn using a variety of monoclonal antibodies. Arch Dis Child (1983) 0.82
Immunoregulation of immunoglobulin production in normal infants and children. Clin Exp Immunol (1985) 0.79
Increased incidence of transient homogeneous immunoglobulins in irradiated and reconstituted C57BL/KaLwRij mice treated with 2'-deoxyguanosine. Clin Exp Immunol (1983) 0.75
Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A (1979) 10.28
A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol (1980) 6.05
Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med (1979) 5.19
Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med (1980) 4.80
Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation. J Immunol (1980) 2.93
Induction of plasma cell differentiation of human fetal lymphocytes: evidence for functional immaturity of T and B cells. J Immunol (1977) 1.94
Regulation of B cell immunoglobulin secretion by functional subsets of T lymphocytes in man. Eur J Immunol (1980) 1.77
Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines. Proc Natl Acad Sci U S A (1979) 1.72
Thymus-derived peripheral lymphocytes from human newborns inhibit division of their mothers' lymphocytes. J Immunol (1976) 1.57
B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes. J Clin Invest (1980) 1.51
Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function. Proc Natl Acad Sci U S A (1979) 1.41
Interaction of maternal and neonatal cells in mixed-lymphocyte cultures. Lancet (1975) 1.40
Differential sensitivity of human leukemic T cell lines and B cell lines to growth inhibition by deoxyadenosine. J Immunol (1978) 1.40
Suppression of B lymphocyte differentiation by newborn T lymphocytes with an Fc receptor for IgM. Clin Exp Immunol (1978) 1.36
Inhibition of suppressor T-cell development following deoxyguanosine administration. Nature (1980) 1.24
Helper and suppressor-inducer activity of human T cells and their cloned progeny maintained in long-term culture. J Immunol (1981) 1.12
Newborn T cell suppression: early appearance, maintenance in culture, and lack of growth factor suppression. J Immunol (1981) 1.07
Induction of suppression through human T cell interactions. Clin Exp Immunol (1980) 0.95
Plaque-forming cells in human cord blood: studies on T and B cell function. Clin Exp Immunol (1980) 0.90
Precursor and effector phenotypes of activated human T lymphocytes. Nature (1980) 0.82
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
IgA deficiency, epilepsy, and phenytoin treatment. Lancet (1975) 2.40
Fc-receptor heterogeneity of human suppressor T cells. J Immunol (1978) 2.37
Electroimmunodiffusion (EID): a simple, rapid method for quantitation of immunoglobulins in dilute biological fluids. J Lab Clin Med (1967) 2.37
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25
Inhibition of complement-dependent lymphocyte rosette formation: a possible test for activated complement products. Eur J Immunol (1974) 2.12
Induction of plasma cell differentiation of human fetal lymphocytes: evidence for functional immaturity of T and B cells. J Immunol (1977) 1.94
Transformations of maps to investigate clusters of disease. Soc Sci Med (1988) 1.89
Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int (2000) 1.66
Delayed separation of the umbilical cord, widespread infections, and defective neutrophil mobility. Lancet (1979) 1.50
The inhibition of complement-dependent lymphocyte rosette formation by the sera of children with steroid-sensitive hephrotic syndrome and other renal diseases. Clin Exp Immunol (1975) 1.49
Varicella-zoster virus infection of human mononuclear cells. Virus Res (1987) 1.46
Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis (1992) 1.45
Primary and secondary abnormalities of T cell subpopulations. Clin Exp Immunol (1978) 1.43
Lymphocyte responses to varicella zoster virus in the elderly. J Clin Immunol (1987) 1.37
Suppression of B lymphocyte differentiation by newborn T lymphocytes with an Fc receptor for IgM. Clin Exp Immunol (1978) 1.36
Treatment of pneumocystis carinii pneumonia in children. Arch Dis Child (1977) 1.33
Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis (1998) 1.27
Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect Immun (1998) 1.27
Serum immunoglobulins in rheumatoid arthritis. J Lab Clin Med (1966) 1.25
Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis (1998) 1.20
Pre-B and B cells in children on leukaemia remission maintenance treatment. Clin Exp Immunol (1979) 1.19
Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch Dis Child (1978) 1.18
Serum immunoglobulin measurement during the first year of life and in immunoglobulin-deficiency states. J Pediatr (1966) 1.18
The effect of renal function on enalapril kinetics. Clin Pharmacol Ther (1985) 1.15
Central failure of B-lymphocyte induction in pan-hypogammaglobulinemia. Clin Immunol Immunopathol (1975) 1.14
Defect of neutrophil mobility with dominant inheritance in a family with Waardenberg's syndrome. Arch Dis Child (1981) 1.14
Helper and suppressor-inducer activity of human T cells and their cloned progeny maintained in long-term culture. J Immunol (1981) 1.12
Characterization of the T lymphocyte colony-forming cells and evidence for the acquisition of T cell markers in the absence of the thymic microenvironment in man. J Immunol (1981) 1.10
Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells. J Virol (1986) 1.10
Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis (1994) 1.10
Development of lymphocyte responses and interactions in the human fetus and newborn. Immunol Rev (1981) 1.08
Newborn T cell suppression: early appearance, maintenance in culture, and lack of growth factor suppression. J Immunol (1981) 1.07
Development of lymphocyte populations in the human foetal thymus and spleen. Clin Exp Immunol (1974) 1.06
Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones. J Virol (1992) 1.04
Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg (1993) 1.03
Characterization of the human newborn response to herpesvirus antigen. J Immunol (1985) 1.02
X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol (2000) 1.02
Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol (1994) 1.01
Influence of vasopressin and angiotensin on baroreflexes in the dog. Circ Res (1984) 0.98
T-lymphocyte subpopulations in insulin-dependent (type I) diabetes mellitus. Clin Exp Immunol (1986) 0.98
Use of bone marrow fibroblasts to prepare targets for an HLA restricted-cytotoxicity assay system. J Clin Microbiol (1984) 0.97
A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. Am J Perinatol (1997) 0.96
Hypogammaglobulinemia, primary and secondary: immunoglobulin levels (gamma-G, gamma-A, gamma-M) in one hundred and twenty-five patients. J Allergy (1966) 0.95
Induction of suppression through human T cell interactions. Clin Exp Immunol (1980) 0.95
Risk of repetition of a severe perineal laceration. Obstet Gynecol (1999) 0.95
Immune responses to varicella zoster virus infections in healthy children. J Infect Dis (1993) 0.94
Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells. J Virol (1986) 0.93
T cell growth factor-enhanced PHA response of human thymus cells: requirement for T3+ cells. J Immunol (1981) 0.92
Growth of pre-B cells in cultures of bone marrow from children with acute lymphoblastic leukaemia and other diseases. Clin Exp Immunol (1981) 0.92
Desferoxamine blocks IL 2 receptor expression on human T lymphocytes. J Immunol (1986) 0.91
Percutaneous management of perianastomotic stenosis in arteriovenous fistulae: results of a prospective study. Kidney Int (2006) 0.91
Culture and phenotype of activated T-cells from patients with type I diabetes mellitus. Diabetes (1984) 0.90
Existence of a pool of T-lymphocyte colony-forming cells (T-CFC) in human bone marrow and their place in the differentiation of the T-lymphocyte lineage. Blood (1981) 0.90
Hypoimmunoglobulinaemia with deficiency of pre-B cells. Lancet (1978) 0.90
Expression of b 4 and b 5 chi light chain allotypes by B and pre-B cells in allotype-suppressed and neutralized b4b5 rabbits. Eur J Immunol (1979) 0.89
Lysis of varicella zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients. Clin Exp Immunol (1985) 0.89
The varicella vaccine. Prevention of herpes zoster. Infect Dis Clin North Am (1996) 0.88
Pre-B cell suppression by thymoma patient lymphocytes. Clin Exp Immunol (1982) 0.88
Phenotype and function of human milk monocytes as antigen presenting cells. Clin Immunol Immunopathol (1982) 0.87
Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity. J Clin Microbiol (1996) 0.87
Pre-B and B cells in rabbits. Ontogeny and allelic exclusion of kappa light chain genes. J Exp Med (1978) 0.86
Processing and presentation of cell-associated varicella-zoster virus antigens by human monocytes. Clin Exp Immunol (1987) 0.85
Immune response to split-product influenza vaccine in preterm and full-term young children. Vaccine (1992) 0.85
Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J Pediatr (1994) 0.84
Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection. Vaccine (1994) 0.84
Accidental penile gangrene. J Urol (1972) 0.83
Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int (1997) 0.83
T cell proliferative response to interleukin 2: different frequency of responders among CD45R0 and CD45RA subsets. Cell Immunol (1990) 0.83
Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines. J Clin Immunol (1986) 0.83
Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus. J Immunol (1984) 0.83
Identification of cells with monocyte markers in panhypogammaglobulinaemia. Scand J Immunol (1975) 0.82
Intact intestinal mRNAs and intestinal epithelial cell esterase, but not Cryptosporidium parvum, reach mesenteric lymph nodes of infected mice. J Immunol (2001) 0.82
Inhibition of varicella-zoster virus in vitro by human peripheral blood mononuclear cells. Clin Exp Immunol (1989) 0.82
Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older. Vaccine (2000) 0.82
Cellular interactions in the lysis of varicella-zoster virus infected human fibroblasts. Clin Exp Immunol (1986) 0.81
Hypergammaglobulinemia--the role of the immunoglobulins (gamma G, gamma A, gamma M). J Allergy (1965) 0.81
Herpes simplex virus-stimulated gamma-interferon production by newborn mononuclear cells. Pediatr Res (1986) 0.81
Neutrophil pyruvate kinase deficiency with recurrent staphylococcal infections: first reported case. Br Med J (1976) 0.81
Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine. Clin Exp Immunol (1980) 0.81
Double fluorescence technique for measurement of complement-fixing antibody to lymphocyte subsets. J Immunol Methods (1985) 0.81
Respiratory syncytial virus infects the Bonnet monkey, Macaca radiata. Pediatr Dev Pathol (1999) 0.80
Probable graft-vs-graft reaction in an infant after exchange transfusion and marrow transplantation. Pediatrics (1982) 0.80
B cell function in the newborn. Pediatrics (1979) 0.80
Requirement for TNF-Tnfrsf1 signalling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum. Clin Exp Immunol (2002) 0.79
Stereoselectivity of tocainide pharmacodynamics in vivo and in vitro. J Cardiovasc Pharmacol (1988) 0.79
Non-specific induction of cytoxicity by human lymphocytes with human IgG. Immunology (1974) 0.79
Early and late fistula failure. Clin Nephrol (2008) 0.79
Sacral nerve root stimulation: a clinical test of detrusor innervation. J Urol (1972) 0.79
Differential response of human thymus cells to CD2 antibodies: fragmentation of DNA of CD45RO+ and proliferation of CD45RO- subsets. Immunology (1992) 0.78
Four families with immunodeficiency and chromosome abnormalities. Arch Dis Child (1979) 0.78
Response of human newborn lymphocytes to alloantigen: lack of evidence for suppression induction. Pediatr Res (1984) 0.78
Failure of a pan-reactive anti-T cell antibody, OKT 3, to prevent graft versus host disease in severe combined immunodeficiency. J Pediatr (1982) 0.78
The human fetus and newborn: development of the immune response. Birth Defects Orig Artic Ser (1983) 0.78
Development of the immune response. Clin Allergy (1973) 0.77
Interactions between color and word processing in a flanker task. J Exp Psychol Hum Percept Perform (1999) 0.77
Noma in children with severe combined immunodeficiency. J Pediatr (1986) 0.77
Phenotyping of proliferating cells in cultures of human lymphocytes. J Immunol Methods (1985) 0.77
Reduced cellular immunity to varicella zoster virus during treatment for acute lymphoblastic leukemia of childhood: in vitro studies of possible mechanisms. J Clin Immunol (1986) 0.77